Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Healthcare Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > What still no news, my heavens!!!
View:
Post by ENEMENEMYNEMO on Dec 03, 2021 3:49pm

What still no news, my heavens!!!

https://apple.news/Ag3aDoOn1SfqJLKQJGtXkHw


Pfizer selling this stuff that has less data than Apabetalone...  and this company is still sitting with its fingers up their a s s es!!!!!

Listen cut the garbage here about debating about patients taking apabetalone as an option when they are admitted..50% chance they are dying...they'll take anything thats offered....and therein lies the problem... RVX hasn't got anyone in there offering anything... it's F'n criminal really....the whole piece of s hit board is complicit....

Comment by geric on Dec 04, 2021 11:32am
I doubt they're even attempting to recruit patients.  In 7 1/2 weeks they can't come up with ONE!  This is beyond ridiculous.  It's all spin from DM.  This company is so untrustworthy and low profile that I'm sure no one would be interested.  When other larger names have been able to trial their products, our team just seeks cooperation and agreements with ...more  
Resverlogix Corp